Compare AMPH & VYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMPH | VYX |
|---|---|---|
| Founded | 1996 | 1881 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 994.1M |
| IPO Year | 2005 | 1996 |
| Metric | AMPH | VYX |
|---|---|---|
| Price | $28.85 | $10.07 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $24.50 | $13.50 |
| AVG Volume (30 Days) | 415.9K | ★ 2.9M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.67 | 0.09 |
| Revenue | $719,887,000.00 | ★ $7,156,000,000.00 |
| Revenue This Year | $3.81 | N/A |
| Revenue Next Year | $4.91 | N/A |
| P/E Ratio | ★ $17.10 | $115.50 |
| Revenue Growth | N/A | ★ 15.29 |
| 52 Week Low | $16.65 | $6.02 |
| 52 Week High | $31.00 | $11.31 |
| Indicator | AMPH | VYX |
|---|---|---|
| Relative Strength Index (RSI) | 64.24 | 69.17 |
| Support Level | $27.24 | $6.46 |
| Resistance Level | $29.35 | $10.12 |
| Average True Range (ATR) | 1.07 | 0.57 |
| MACD | 0.15 | 0.17 |
| Stochastic Oscillator | 61.97 | 76.67 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in two reportable segments: Retail, and Restaurants. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The company derives maximum revenue from Retail segment. Geographically, the company operates in United States, Americas (excluding United States), Europe, Middle East and Africa, and Asia Pacific. It derives maximum revenue from United States.